Celularity Inc - Ordinary Shares - Class A Stock price
Is Celularity Inc - Ordinary Shares - Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.
Key metrics
Celularity Inc - Ordinary Shares - Class A Stock Analysis
Analyst Opinions
7 Analysts have issued a Celularity Inc - Ordinary Shares - Class A forecast:
Analyst Opinions
7 Analysts have issued a Celularity Inc - Ordinary Shares - Class A forecast:
Don't miss a Thing! We will send you all news about Celularity Inc - Ordinary Shares - Class A directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Celularity Inc - Ordinary Shares - Class A Stock News
Company Profile
Celularity, Inc. a clinical stage biotechnology company, discovers cancer sub-types and therapeutic options for cancer patients in the United States. The firms CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. It is also developing CELsignia MP test, a qualitative laboratory developed test that measures HER2, c-Met, and PI3K signaling activity in breast and ovarian tumor cells. The company is headquartered in Florham Park, NJ.
| Head office | United States |
| CEO | Dr. Hariri |
| Employees | 115 |
| Founded | 2016 |
| Website | celularity.com |


